创模生物科技(北京)有限公司

CN / En

NEWS

InnoModels Biotechnology: Unique Features of Luminex Technology

  • Categories:Company news
  • Author:InnoModels Biotechnology
  • Origin:InnoModels Biotechnology
  • Time of issue:2024-01-31 15:57
  • Views:

(Summary description)Pushing the boundaries of technological innovation and leading the way to a new era of multiplexed assays, InnoModels Biotechnology has once again introduced its highly regarded Luminex technology. This technology has emerged as a leader in biomedical research, clinical diagnostics and drug discovery, and its unique features provide researchers with unprecedented flexibility and efficiency

InnoModels Biotechnology: Unique Features of Luminex Technology

(Summary description)Pushing the boundaries of technological innovation and leading the way to a new era of multiplexed assays, InnoModels Biotechnology has once again introduced its highly regarded Luminex technology. This technology has emerged as a leader in biomedical research, clinical diagnostics and drug discovery, and its unique features provide researchers with unprecedented flexibility and efficiency

  • Categories:Company news
  • Author:InnoModels Biotechnology
  • Origin:InnoModels Biotechnology
  • Time of issue:2024-01-31 15:57
  • Views:
Information

Pushing the boundaries of technological innovation and leading the way to a new era of multiplexed assays, InnoModels Biotechnology has once again introduced its highly regarded Luminex technology. This technology has emerged as a leader in biomedical research, clinical diagnostics and drug discovery, and its unique features provide researchers with unprecedented flexibility and efficiency.
The outstanding features of Luminex technology
1. Multi-analytical capabilities:
InnoModels Bio's Luminex technology stands out for its unique multi-analytical capabilities. The microbead technology enables the simultaneous detection of multiple biomarkers, enabling high-throughput analysis of complex biological samples. This feature enables researchers to obtain more comprehensive data in a single experiment, saving time and resources.
2. High sensitivity and accuracy:
Luminex technology is recognized for its superior sensitivity and accuracy. The fluorescent markers on the beads can be detected at very low concentrations, providing researchers with an extremely sensitive analytical tool to detect changes in trace biomarkers, which is important for early disease diagnosis and monitoring.
3. High throughput and rapidity:
Luminex technology enables high-throughput analysis and, through its automated processes, is able to process large numbers of samples in a short period of time. This provides an efficient solution for large-scale studies and clinical trials, enabling researchers to access large-scale data more quickly and advancing the scientific research process.
4. Diverse range of applications:
The technology is widely used in biomedical research, immunology, infection virus monitoring, cancer marker research and other fields. The diversity of applications provides researchers with the flexibility to adapt to different research needs.
5. Customized experimental design:
Luminex technology supports customized experimental design, allowing researchers to select the biomarkers to be tested according to the specific purpose of the study, thus better meeting the needs of individual experiments.

 


Scientific Applications and Future Prospects
1. Immunology research:
In the field of immunology, the multi-analysis capability of Luminex technology provides the possibility of simultaneous detection of multiple immune indicators such as inflammatory factors and cytokines, which is expected to provide more comprehensive data support for in-depth research on the immune mechanisms of diseases.
2. Drug development and clinical trials:
In drug development and clinical trials, the high throughput and rapidity of Luminex technology provides an efficient means of evaluating drug effects and monitoring biomarker changes in clinical trial participants.
3. Cancer marker studies:
Luminex technology also performs well in cancer marker studies, and is expected to provide more accurate molecular information for early diagnosis and treatment strategies for cancer.
Conclusion
With its excellent features, Luminex technology from InnoModels Biotechnology provides researchers with a new multidimensional assay tool to help life science research move into a deeper and broader field. With continuous upgrades and innovations, InnoModels Biotechnology is expected to continue to lead the development of Luminex technology, bringing more cutting-edge applications to biomedical research, clinical diagnostics and drug discovery.

Keyword:

In the vast field of oncology and tumor immunopharmacodynamics research, InnoModels Biotechnology (Beijing) Ltd. has become a leader in the industry with its outstanding innovation ability and profound scientific research background. This company, co-founded by scientists from Novo Nordisk China R&D Center, Sino-US Crown and Shanghai Jiao Tong University Institute of Immunology, has been committed to building a stable domestic platform of humanized mouse models of the immune system (HIS) and human tumor xenografts (PDX) since its establishment in 2020, to provide new drug discovery and development companies, translational medicine researchers, and tumor patients with new-generation laboratory animal models for new drug discovery companies, translational medicine researchers, and tumor patients
In recent years, many breakthroughs have been made in the field of biomedical research, among which iHuPBMC-T technology is undoubtedly a shining star. As an innovative platform built by InnoModels Biotechnology (Beijing) Co., Ltd, iHuPBMC-T, with its unique technological advantages, shows great potential in optimizing the reconstruction of human peripheral blood single nucleated cell (PBMC) model and immuno-oncology research.
Recently, InnoModels Biotechnology (Beijing) Co., Ltd. has made a major breakthrough in the field of pharmaceutical technology, and successfully obtained a patent entitled “Method and application for the detection of immune system rebuilding ability of PBMC”. This patent not only adds a new footnote to the R&D strength of InnoModels Biotechnology in the field of biomedicine, but also provides a strong technical support for the promotion of drug research and development and the establishment of humanized experimental animal models
With the rapid development of biotechnology, the in-depth study of the immune system has become the key to new drug discovery, disease diagnosis and treatment. InnoModels Bio-technology (Beijing) Co., Ltd. provides strong support for researchers with its profound scientific background and advanced technology platform. Among them, the ELISpot platform of InnoModels Biotechnology has made a name for itself in the field of immunology research with its high sensitivity and multi-functionality
InnoModels' ADCC platform plays a pivotal role in advancing cancer treatment, and its unique technological advantages and innovative concepts have brought about a far-reaching impact on the field of tumor immunotherapy. The following is a detailed introduction of how the platform promotes the advancement of cancer treatment
In the field of tumor immunotherapy, complement-dependent cytotoxicity (CDC), as an important therapeutic mechanism, is gradually showing its great potential and value. In order to explore this mechanism more deeply, with its profound accumulation in the field of oncology and tumor immunopharmacodynamics CRO services, InnoModels Biotechnology (Beijing) Co., Ltd. has launched the CDC in vitro immune-tumor cell co-culture killing experimental platform, which provides researchers with a powerful and precise tool to help innovate cancer treatment
Previous page
1
2
43
  • Tel 15010000264
  • E-mail limy@imodels.tech
  • Tel 13810723384
  • Top

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL:15010000264        13810723384

Address:Building 14, Life Valley, Shuangying West Road, Changping District, Beijing

Chuangmo Biotechnology (Beijing) Co., Ltd. Beijing ICP 222*** 98-1 Website Construction: China Enterprise Power Beijing Second Branch Company

北京中因科技有限公司

创模生物科技(北京)有限公司